Sign up to our newsletter Subscribe
The Importance of Diversity of Supply in Rare Diseases Markets

As more and more medicines come to market with multiple indications or the unrealised potential to treat multiple indications, the way we pay for those medicines becomes critical in making sure we can benefit from them. Indication-based pricing (IBP) permits price to vary according to indication and has been proposed to tackle this issue.